Uncovering the characteristics of the gut microbiota in patients with ischemic stroke and hemorrhagic stroke

Yu-Zhu Chen,Zhao-Yong Huang,Wei-Wen Zhou,Zhong-You Li,Xiao-Peng Li,Shi-Shi Chen,Jin-Kui Ma
DOI: https://doi.org/10.1038/s41598-024-62606-x
IF: 4.6
2024-05-25
Scientific Reports
Abstract:This study aimed to explore the gut microbiota characteristics of ischemic and hemorrhagic stroke patients. A case–control study was conducted, and high-throughput sequencing of the V4–V5 region of 16S rRNA was used to analyze the differences in gut microbiota. The results showed that Proteobacteria was significantly increased in the ischemic stroke group compared with the healthy control group, while Fusobacteria was significantly increased in the hemorrhagic stroke group. In the ischemic stroke group, Butyricimonas , Alloprevotella , and Escherichia were significantly more abundant than in the healthy control group. In the hemorrhagic stroke group, Atopobium , Hungatella , Eisenbergiella , Butyricimonas , Odonbacter , Lachnociostridium , Alistipes , Parabacteroides , and Fusobacterium were significantly more abundant than in the healthy control group. Additionally, Alloprevotella , Ruminococcus , and Prevotella were significantly more abundant in the ischemic stroke group than in the hemorrhagic stroke group. The gut microbiota of ischemic and hemorrhagic stroke patients has significant diversity characteristics. These results provide new theoretical basis for exploring the prevention and treatment of different types of stroke through gut microbiota research.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the gut microbiota characteristics of patients with ischemic stroke and hemorrhagic stroke. Specifically, the study analyzed the V4 - V5 region of 16S rRNA through high - throughput sequencing technology and compared the differences in gut microbiota between patients with ischemic stroke, patients with hemorrhagic stroke and the healthy control group. The main purposes of the study are: 1. **Determine the gut microbiota characteristics of ischemic stroke and hemorrhagic stroke**: By comparing the gut microbiota compositions of different groups, identify which bacterial groups are significantly increased or decreased in patients with ischemic stroke and hemorrhagic stroke. 2. **Reveal the relationship between different types of stroke and gut microbiota**: Explore whether these microbiota characteristics can be used as biomarkers for different types of stroke, providing a theoretical basis for further prevention and treatment. ### Main findings - **Ischemic stroke group**: Proteobacteria were significantly increased, and the abundances of Butyricimonas, Alloprevotella and Escherichia were significantly higher than those in the healthy control group. - **Hemorrhagic stroke group**: Fusobacteria were significantly increased, and the abundances of Atopobium, Hungatella, Eisenbergiella, Butyricimonas, Odoribacter, Lachnoclostridium, Alistipes, Parabacteroides and Fusobacterium were significantly higher than those in the healthy control group. - **Differences between the ischemic stroke group and the hemorrhagic stroke group**: The abundances of Alloprevotella, Ruminococcus and Prevotella in the ischemic stroke group were significantly higher than those in the hemorrhagic stroke group. ### Significance These results provide a new theoretical basis for exploring the prevention and treatment of different types of stroke through gut microbiota research. In particular, the study reveals the significant diversity characteristics of gut microbiota composition in patients with different types of stroke, which may be helpful for developing personalized intervention and treatment strategies for specific types of stroke.